ABOUT CZECRIN

CZECRIN is a large research infrastructure, established by a decision of the Ministry of Education, Youth and Sports (MoEYS), which also funds it from the special-purpose support for large research infrastructures. The decision on the establishment of the research infrastructure was signed on 21 March 2014, based on the cooperation between Masaryk University (MU; host institution) and St. Anne’s University Hospital in Brno (FNUSA; partner institution) with the aim of creating a nationwide scientific network of partners for conducting non-commercial clinical research and clinical trials at national and international level. For the years 2020 – 2022, the large research infrastructure project has been granted a financial subsidy from the Ministry of Education and Science (LM2018128). Similarly to other clinical research infrastructures within ECRIN-ERIC, LRI CZECRIN does not have the status of a legal entity. The legal entity and host institution of CZECRIN is Masaryk University (MU), one of the leading Central European scientific institutions. The research infrastructures operated by MU are an important pillar of the research and innovation systems in the Czech Republic. Their importance is underlined by their participation in 16 research infrastructures listed in the Czech National Roadmap for Large RDI Infrastructures. Nine of these projects are also part of research infrastructures of pan-European interest included in the European Strategic Forum for Research Infrastructures (ESFRI). Eight research infrastructures are in the field of health and nutrition.

FNUSA – the founding partner – is a university hospital with excellent clinical research capabilities concentrated in the International Center for Clinical Trials (ICRC). Its support in the areas of clinical site network coordination, technical and administrative support is an essential part of CZECRIN.

Currently, the large research infrastructure CZECRIN is a national and fully functional research infrastructure supporting and implementing academic clinical research in the Czech Republic. It provides unique expertise, research, development, production and implementation capabilities in the medical sciences. CZECRIN supports national and international collaboration in clinical research for the benefit of patients, citizens and healthcare. All of this is encompassed by CZECRIN’s new comprehensive strategy with a vision characterized by the slogan: “…towards patient-oriented medicine.”